Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019;15(4):262-273.
doi: 10.2174/1573403X15666181224113855.

Percutaneous Pulmonary Valve Implantation: Current Status and Future Perspectives

Bart W Driesen  1   2 , Evangeline G Warmerdam  1 , Gert-Jan Sieswerda  1 , Folkert J Meijboom  1 , Mirella M C Molenschot  1 , Pieter A Doevendans  1   3   4 , Gregor J Krings  1 , Arie P J van Dijk  2 , Michiel Voskuil  1
Affiliations
Review

Percutaneous Pulmonary Valve Implantation: Current Status and Future Perspectives

Bart W Driesen et al. Curr Cardiol Rev. 2019.

Abstract

Patients with congenital heart disease (CHD) with right ventricle outflow tract (RVOT) dysfunction need sequential pulmonary valve replacements throughout their life in the majority of cases. Since their introduction in 2000, the number of percutaneous pulmonary valve implantations (PPVI) has grown and reached over 10,000 procedures worldwide. Overall, PPVI has been proven safe and effective, but some anatomical variations can limit procedural success. This review discusses the current status and future perspectives of the procedure.

Keywords: Congenital heart disease; melody; percutaneous pulmonary valve implantation; right ventricular outflow tract dysfunction; sapien; transcatheter pulmonary valve replacement..

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
The Melody transcatheter pulmonary valve (Medtronic, Minneapolis, Minn, USA).
Fig. (2)
Fig. (2)
The Edwards SApien XT (Edwards Lifesciences, Irvine, Ca, USA) for implantation in valved conduits and non-conduit (native) RVOT.
Fig. (3)
Fig. (3)
3DRA showing critical proximity of LCA to posterior MPA, not suitable for PPVI.
Fig. (4)
Fig. (4)
A and B; 3D rotational angiography in patient with severe homograft stenosis. C and D; angiographic images after implantation of 3 covered CP stents and Sapien 20mm..tiff.
Fig. (5)
Fig. (5)
The Alterra Adaptive Prestent (Edwards Lifesciences, Irvine, CA, USA).
Fig. (6)
Fig. (6)
The Harmony Transcatheter Pulmonary valve (Medtronic, Minneapolis, MN, USA).
Fig. (7)
Fig. (7)
The RVOT reducer device. Courtesy of Y. Boudjemline, permission to re-use granted.
See this image and copyright information in PMC

References

    1. Krasuski R.A., Bashore T.M. Congenital heart disease epidemiology in the United States: Blindly feeling for the charging elephant. Circulation. 2016;134(2):110–113. - PubMed
    1. Moons P., Bovijn L., Budts W., Belmans A., Gewillig M. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation. 2010;122(22):2264–2272. - PubMed
    1. van der Bom T., Bouma B.J., Meijboom F.J., Zwinderman A.H., Mulder B.J. The prevalence of adult congenital heart disease, results from a systematic review and evidence based calculation. Am. Heart J. 2012;164(4):568–575. - PubMed
    1. Davlouros P.A., Karatza A.A., Gatzoulis M.A., Shore D.F. Timing and type of surgery for severe pulmonary regurgitation after repair of tetralogy of Fallot. Int. J. Cardiol. 2004;97(Suppl. 1):91–101. - PubMed
    1. Bonhoeffer P., Boudjemline Y., Saliba Z., et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356(9239):1403–1405. - PubMed